A Double-blind, Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy.

Trial Profile

A Double-blind, Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Myoclonic epilepsies
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 01 May 2012 This trial is recruiting in Czech Republic, Poland and Spain as reported by EudraCT (Parent trial: EudraCT2007-003556-10).
    • 01 May 2012 This trial is recruiting in Czech Republic, Poland and Spain as reported by EudraCT (Parent trial: EudraCT2007-003556-10).
    • 28 Apr 2012 Planned number of patients changed from 4 to 11 as reported by EudraCT (Parent trial: EudraCT2007-003556-10).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top